MYLAN DUBLIN A. DIVISION OF MCDERMOTT LABORATORIES

It is a factory.

Company Introduction:

MYLAN DUBLIN A. DIVISION OF MCDERMOTT LABORATORIES is a manufacturing facility, operating as part of Mylan N.V. (now Viatris), a global pharmaceutical and healthcare company. This entity functions as a factory, primarily engaged in the production of pharmaceutical products. Mylan is renowned for developing, manufacturing, and distributing generic and specialty medicines, including active pharmaceutical ingredients (APIs) and finished dosage forms. The "McDermott Laboratories" designation likely refers to a specific operational unit or a historical legal entity within Mylan's extensive manufacturing network, contributing to the company's global supply chain for vital medications.

Mylan Dublin A. Division of McDermott Laboratories refers to a historical entity that became part of Mylan, which subsequently merged with Upjohn to form Viatris. Therefore, this specific division does not independently produce or sell products under this exact name today.

However, Mylan, including its integrated divisions like the former McDermott Laboratories, was a major pharmaceutical company in India known for a broad portfolio of generic and specialty medicines.

The products manufactured or sold by Mylan (which would encompass the activities of its integrated divisions) in India typically included:

Antiretroviral medications for HIV/AIDS.

Oncology products for cancer treatment.

Cardiovascular drugs for heart and circulatory conditions.

Central Nervous System drugs for neurological and psychiatric disorders.

Anesthesia and pain management products.

Anti-infectives such as antibiotics, antifungals, and antivirals.

Respiratory products for conditions like asthma and COPD.

Dermatology products.

Biosimilars.

A wide range of generic pharmaceuticals across various therapeutic areas.